MedPath

Evaluation of the Sarcopenia in Hepatobiliary Surgery

Terminated
Conditions
Postoperative Complications
Sarcopenia
Hepatobiliary Disease
Surgery
Registration Number
NCT03754452
Lead Sponsor
University Hospital, Angers
Brief Summary

The sarcopenia is defined as a loss of muscle mass and a loss of muscle function ( strength or performance). Some studies showed that the sarcopenia increase the postoperative complications and the overall survival in abdominal surgery. But the sarcopenia is not evaluated in the Hepatobiliary surgery. This prospective, monconcentrique study aim to evaluate the prevalence of sarcopenia, and its associated morbimortality in hepatobiliary surgery for malignant or benign tumors.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • hepatobiliary surgery
  • scheduled surgery
  • oral consent
Exclusion Criteria
  • pregnancy
  • patient under low protection
  • emergency surgery
  • hepatic encephalopathy stage II, III and IV

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the number of patients with a sarcopenia before having a hepatobiliary surgery mesured by impedancemetry and by the muscular force or the speed walking1 month

for the woman: i/impedancemetry BMI\<6,42kg/m2 and ii/muscular force \< 20kg or a walking speed \<0,8m/s

Secondary Outcome Measures
NameTimeMethod
comparison between the impedancemetry and the abdominopevis CT for the diagnosis of sarcopenia3 months

* impedancemetry used to evaluate the muscular mass

* abdominopelvis CT evualate the muscular mass by measuring the muscular area on the L3 section

comparison of the postoperatives complications using the clavien dindo classsification between the patient with sarcopenia and the patient without sarcopenia.4 months

postoperatives complications evualuated according the clavien dindo classification are : death, nausea, vomit, need of nasogastric tube, liver failure with jaundice, ascites, liver encephalopathy, biliary fistula, biliary peritonitis, hernia, parietal abcess, urinary infection, urinary retention, hematoma, pulmonary embolism, pulmonary infection, pleural effusion, atelectasis, renal failure, hyponatremia, hypernatremia, hypokaliema, hyperkaliema the post operative complication evaluate

Trial Locations

Locations (1)

CHU Angers

🇫🇷

Angers, France

© Copyright 2025. All Rights Reserved by MedPath